MedTrace Logo

Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment

NCT01765075 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2014-03-05

No results posted yet for this study

Summary

The purpose of the study is to gather electrophysiological data using a multi-electrode mapping catheter during a clinically indicated cardiac ablation procedure for the treatment of persistent atrial fibrillation.

Conditions

  • Permanent Atrial Fibrillation

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Jas Gill, MA MD FRCP FACC · Guys & St. Thomas' Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Czechia
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01765075 on ClinicalTrials.gov